Senseonics Receives European Approval for Eversense 365, World's Longest-lasting Continuous Glucose Monitor

Stock Information for Hyperfine Inc.

Loading

Please wait while we load your information from QuoteMedia.

More Recent News About Hyperfine Inc.

The Quiet Rule Change Tilting $10B Toward Medtech's Most Validated Platforms
Senseonics Announces European Launch of Eversense® 365, The World's First and Only One Year CGM System
MedTech's Edge: How AI and Remote Diagnostics Drive Scalable Value
First Ever Real-World Evidence of Eversense 365 Presented at ATTD Demonstrates Sustained Performance and Positive Impact Throughout One-Year of Wear
Senseonics Holdings, Inc. Reports Fourth Quarter and Full Year 2025 Financial Results
Sequel Med Tech and Senseonics Launch Transformative Combination of twiist(TM) and Eversense® 365
Sequel Med Tech and Senseonics Launch Transformative Combination of twiist(TM) and Eversense® 365
Senseonics Holdings, Inc. to Participate at the BTIG 13th Annual MedTech, Digital Health, Life Science & Diagnostic Tools Conference

Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.